Search results
Results From The WOW.Com Content Network
At about $69 per share, DexCom's stock isn't that far off its 52-week low of $62.34 and is miles away from its 52-week high of $142. However, there remain good reasons to invest in the company ...
DXCM Revenue (TTM) data by YCharts. What's more, the business is pursuing new avenues for growth by entering into international markets like the U.K., Germany, Japan, Spain, Bulgaria, Romania, and ...
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels. The company slashed its forecast last year, blaming a ...
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. [3] [4] In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours.
DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.
Stocks with the highest dividend yields in the Dow Jones Industrial Average *Data below as of Jan. 9, 2025. 1. Verizon Communications (VZ) Verizon is a leader in communication and technology ...
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
DexCom (DXCM) closed the most recent trading day at $393, moving -1.44% from the previous trading session.